Ardent Health, Inc.
Case Overview
| Status: | Status: Investigating |
| Company Name: | Company Name: Ardent Health, Inc. |
| Ticker: | Ticker: ARDT |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
Contact Instructions
The law firm of Kirby McInerney LLP is investigating potential claims against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE:ARDT). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
On November 12, 2025, Ardent issued a press release announcing its financial results for the third quarter of 2025. In connection with that release, the Company disclosed that it recorded a $43 million reduction in revenue due to a change in accounting estimates regarding the collectability of accounts receivable. Ardent also revealed a $54 million increase to its professional liability reserves related to claims arising in New Mexico. On this news, the price of Ardent shares declined by $4.75 per share, or approximately 33.8%, from $14.05 per share on November 12, 2025 to close at $9.30 on November 13, 2025.
On November 12, 2025, Ardent issued a press release announcing its financial results for the third quarter of 2025. In connection with that release, the Company disclosed that it recorded a $43 million reduction in revenue due to a change in accounting estimates regarding the collectability of accounts receivable. Ardent also revealed a $54 million increase to its professional liability reserves related to claims arising in New Mexico. On this news, the price of Ardent shares declined by $4.75 per share, or approximately 33.8%, from $14.05 per share on November 12, 2025 to close at $9.30 on November 13, 2025.